SafeScript – real-time prescription monitoring

SafeScript is a clinical decision support system that allows doctors and pharmacists to access an up-to-the-minute medicines supply history of certain high-risk medicines for their patient at the point of consultation.

The SafeScript system is accompanied by a range of initiatives to support and prepare patients and health professionals for the implementation of SafeScript. This includes:

  • A public awareness campaign to inform the general public of SafeScript and to improve the understanding of the risks associated with some prescription medicines
  • Training for prescribers and pharmacists, on how to more safely prescribe and dispense high-risk medications and respond to the needs of patients.

SafeScript Training Hub

A new SafeScript Training Hub is available, 'one-stop' online hub for SafeScript. The SafeScript Training Hub includes information about the SafeScript system, training, technical support and an extensive list of resources.

SafeScript Training

Online CPD-accredited training on SafeScript is available here via the SafeScript Training Hub.

SEMPHN hosted six SafeScript training sessions for prescribers and pharmacists in 2019 across:

DHHS SafeScript Website

For further information on Safescript, including access to technical and non-technical support, visit the Department of Health and Human Services (DHHS) SafeScript website.

SafeScript Portal

The SafeScript system itself can be accessed here by prescribers and pharmacists.  Eventually, the system will be integrated into most prescribing and dispensing software. 

Practice Managers

A document answering practice managers' most frequently asked questions regarding SafeScript is available here

General Practitioners  

There is a General Practitioner Clinical Advisory Service (GPCAS) that assists GPs with patient issues relating to high-risk prescription medications.

GPCAS is a peer to peer advice and mentoring service.

GPCAS Clinical Advisors are GPs who have completed a comprehensive program in the management of pain, anxiety, insomnia and associated addiction and receive ongoing supervision and peer reviews by addiction medicine, addiction psychiatry and pain medicine specialists.

To use GPCAS call the Drug and Alcohol and Clinical Advisory Service (DACAS) on 1800 812 804 and ask to be referred to a GPCAS Clinical Advisor in your local area.

Within two (2) business days a SafeScript GPCAS Clinical Advisor will be in contact with you to provide advice.

Managing opioid dependence

This email address is being protected from spambots. You need JavaScript enabled to view it.for a visit from our pharmacotherapy team about managing opioid dependence in general practice and in the pharmacy setting.  With the implementation of SafeScript, it’s an important time for prescribers and pharmacists to become skilled and confident in prescribing or dispensing pharmacotherapies for opioid dependence (buprenorphine and methadone). 

Any GP can prescribe buprenorphine/naloxone for up to 5 patients without completing additional training.  More information is available in this 16 minute video and 4 page guide.

The Area 4 Pharmacotherapy Network offers free support to prescribers and pharmacists, including advice and guidance from addiction medicine specialists, GP mentors and experienced pharmacists.

More information about this initiative is available here.


Associated tags

Back to top

Font Size A+ A= A-

Funding Opportunities

Tenders, Quotes & Expression of Interest Portal

If you’re interested in applying for funding opportunities, register your interest on SEMPHN's eProcure page. Once you register, you’ll receive information as it’s released.

Register

Subscribe to latest updates from SEMPHN